Home › Samsung Gets European Approval for Enbrel Copy
 

Keywords :   


Samsung Gets European Approval for Enbrel Copy

2016-01-17 23:01:19| Semiconductors - Topix.net

Samsung Group said it has won approval from regulators to sell a near-replica of the blockbuster rheumatoid arthritis drug Enbrel in Europe, marking an early milestone for South Korea's biggest conglomerate in the nascent market for so-called biosimilar drugs.

Tags: copy european samsung approval

Category:Electronics and Electrical

Latest from this category

All news
»
16.05The man who turned his dead father into a chatbot
16.05Firms leaving UK 'not a crisis' says stock market boss
15.05Exploring the future of agriculture
15.05American, Mexican, and Canadian cattle producers sign joint statement
15.05Attitudes EWG Verified Skincare Line Oceanly Expands with SPF Offerings
15.05Sherwin-Williams Packaging Coatings Expands Non-BPA Coatings Production in Europe
15.05Voesh Unveils Body Refining Roller Crme Ahead of Summer 2024
15.05KANSAI HELIOS Completes Acquisition of WEILBURGER Coatings
More »